CLINICAL_TRIALS
trial_result
· 2013-08-23
Clinical Trial Update: Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 clinical trial update from AstraZeneca reports results evaluating efficacy and safety in Japanese subjects with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes, High Blood Sugar | Phase 3 | Status: COMPLETED | Results posted: 2013-08-23